Literature DB >> 16366737

Neurodegeneration from mitochondrial insufficiency: nutrients, stem cells, growth factors, and prospects for brain rebuilding using integrative management.

Parris M Kidd1.   

Abstract

Degenerative brain disorders (neurodegeneration) can be frustrating for both conventional and alternative practitioners. A more comprehensive, integrative approach is urgently needed. One emerging focus for intervention is brain energetics. Specifically, mitochondrial insufficiency contributes to the etiopathology of many such disorders. Electron leakages inherent to mitochondrial energetics generate reactive oxygen free radical species that may place the ultimate limit on lifespan. Exogenous toxins, such as mercury and other environmental contaminants, exacerbate mitochondrial electron leakage, hastening their demise and that of their host cells. Studies of the brain in Alzheimer's and other dementias, Down syndrome, stroke, Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, Huntington's disease, Friedreich's ataxia, aging, and constitutive disorders demonstrate impairments of the mitochondrial citric acid cycle and oxidative phosphorylation (OXPHOS) enzymes. Imaging or metabolic assays frequently reveal energetic insufficiency and depleted energy reserve in brain tissue in situ. Orthomolecular nutrients involved in mitochondrial metabolism provide clinical benefit. Among these are the essential minerals and the B vitamin group; vitamins E and K; and the antioxidant and energetic cofactors alpha-lipoic acid (ALA), ubiquinone (coenzyme Q10; CoQ10), and nicotinamide adenine dinucleotide, reduced (NADH). Recent advances in the area of stem cells and growth factors encourage optimism regarding brain regeneration. The trophic nutrients acetyl L-carnitine (ALCAR), glycerophosphocholine (GPC), and phosphatidylserine (PS) provide mitochondrial support and conserve growth factor receptors; all three improved cognition in double-blind trials. The omega-3 fatty acid docosahexaenoic acid (DHA) is enzymatically combined with GPC and PS to form membrane phospholipids for nerve cell expansion. Practical recommendations are presented for integrating these safe and well-tolerated orthomolecular nutrients into a comprehensive dietary supplementation program for brain vitality and productive lifespan.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16366737

Source DB:  PubMed          Journal:  Altern Med Rev        ISSN: 1089-5159


  21 in total

Review 1.  JNK: a stress-activated protein kinase therapeutic strategies and involvement in Alzheimer's and various neurodegenerative abnormalities.

Authors:  Sidharth Mehan; Harikesh Meena; Deepak Sharma; Rameshwar Sankhla
Journal:  J Mol Neurosci       Date:  2010-09-28       Impact factor: 3.444

2.  Effects of Gingko Extract (EGb761) on oxidative damage under different conditions of serum supply.

Authors:  Chun Shi; Zhibing Yao; Jie Xu; David T Yew
Journal:  J Bioenerg Biomembr       Date:  2009-02-11       Impact factor: 2.945

3.  Improvement of short-term memory performance in aged beagles by a nutraceutical supplement containing phosphatidylserine, Ginkgo biloba, vitamin E, and pyridoxine.

Authors:  Joseph A Araujo; Gary M Landsberg; Norton W Milgram; Alda Miolo
Journal:  Can Vet J       Date:  2008-04       Impact factor: 1.008

4.  Mercury induces inflammatory mediator release from human mast cells.

Authors:  Duraisamy Kempuraj; Shahrzad Asadi; Bodi Zhang; Akrivi Manola; Jennifer Hogan; Erika Peterson; Theoharis C Theoharides
Journal:  J Neuroinflammation       Date:  2010-03-11       Impact factor: 8.322

5.  A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia.

Authors:  A Chan; R Remington; E Kotyla; A Lepore; J Zemianek; T B Shea
Journal:  J Nutr Health Aging       Date:  2010-03       Impact factor: 4.075

Review 6.  α-Lipoic Acid, an Organosulfur Biomolecule a Novel Therapeutic Agent for Neurodegenerative Disorders: An Mechanistic Perspective.

Authors:  Heena Khan; Thakur Gurjeet Singh; Randhir Singh Dahiya; Mohamed M Abdel-Daim
Journal:  Neurochem Res       Date:  2022-04-21       Impact factor: 3.996

Review 7.  Lipoic Acid and Other Antioxidants as Therapies for Multiple Sclerosis.

Authors:  Carin Waslo; Dennis Bourdette; Nora Gray; Kirsten Wright; Rebecca Spain
Journal:  Curr Treat Options Neurol       Date:  2019-05-06       Impact factor: 3.598

8.  Oxidative stress is differentially present in multiple sclerosis courses, early evident, and unrelated to treatment.

Authors:  Maira Gironi; Bruno Borgiani; Enrica Mariani; Cristina Cursano; Laura Mendozzi; Rossella Cavarretta; Marina Saresella; Mario Clerici; Giancarlo Comi; Marco Rovaris; Roberto Furlan
Journal:  J Immunol Res       Date:  2014-03-26       Impact factor: 4.818

9.  Plasma Metabolomics Profiling in Maintenance Hemodialysis Patients Based on Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry.

Authors:  Yu Chen; Ping Wen; Junwei Yang; Jianying Niu
Journal:  Kidney Dis (Basel)       Date:  2020-02-07

10.  The effects of acute and prolonged CRAM supplementation on reaction time and subjective measures of focus and alertness in healthy college students.

Authors:  Jay R Hoffman; Nicholas A Ratamess; Adam Gonzalez; Noah A Beller; Mattan W Hoffman; Mark Olson; Martin Purpura; Ralf Jäger
Journal:  J Int Soc Sports Nutr       Date:  2010-12-15       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.